Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis

Compliance Rate After Therapy of Peri-implantitis: Retrospective Study

Peri-implantitis is a plaque-mediated inflammatory condition featured by progressive bone loss. This entity jeopardizes the longevity of dental implants, thus impacting negatively on the quality of life of patients. Moreover, peri-implantitis is suggested to lead to an increased systemic status of inflammation. This may rise the susceptibility to experience life-threating conditions. Therefore, peri-implant infections must be promptly diagnosed and eliminated.

Aiming at resolving the inflammation, several options are advised to remove the infection. Accordingly, implant removal or therapeutic manoeuvres to stablish a healthy ecosystem in the peri-implant environment have been suggested. While the former proved being more predictable, the later demonstrated being more conservative. Indeed, implant removal is commonly associated with regenerative procedures of the alveolar bone deformity that often demand time and is more costly. Anyways, disease severity, implant expendability for biomechanical reasons or esthetic demand seem to be few of the leading aspects in the decision-making process on maintaining or extracting implant showing peri-implant lesions.

Supportive maintenance care (SPT) was shown to be key in preventing disease recurrence. Nonetheless, the compliance of these patients is often erratic. In fact, it is yet unknown the rate of compliance after therapy. Therefore, the goal of this study is to assess the rate and confounders for compliance.

Study Overview

• Status: Completed
• Conditions: Peri-Implantitis
• Intervention / Treatment: Other: Assess compliance rate and demographics

• Study Type: Observational
• Enrollment (Actual): 140

Contacts and Locations

Study Locations

• Spain
  • Badajoz, Spain, 06011
    • Centro de Implantologia Cirugia Oral y Maxilofacial

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

Patients that underwent therapy of peri-implantitis and were recommended to SPT

Description

Inclusion Criteria:

• Patients that underwent treatment of peri-implantitis
• >12 months of follow-up after therapy
• Patients managed in our center

Exclusion Criteria:

• Patients that were managed in other centers
• Patients that have incomplete records

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Compliers; Attending to SPT every 4-6 months	Other: Assess compliance rate and demographics; Records to evaluate attendance rate
Erratic compliers; Attending to SPT once a year or sporadically	Other: Assess compliance rate and demographics; Records to evaluate attendance rate
Non compliers; Non-attenders to SPT	Other: Assess compliance rate and demographics; Records to evaluate attendance rate

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Compliance rate	How many patients are complete compliers	1 to 6 years of follow-up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Demographics	Evaluate the patient-related features affecting compliance	1 to 6 years of follow-up

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cumulative Interceptive Rate	Interventions needed after active therapy to manage peri-implantitis during supportive peri-implant care for erratic and regular compliers	1 to 6 years of follow-upo

Collaborators and Investigators

• Sponsor: Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
• Investigators: Study Chair: Mamen Tomé, DH, Assistant

Study record dates

Study Major Dates

• Study Start (Actual): July 1, 2023
• Primary Completion (Actual): July 1, 2023
• Study Completion (Actual): October 30, 2023

Study Registration Dates

• First Submitted: March 6, 2023
• First Submitted That Met QC Criteria: March 6, 2023
• First Posted (Actual): March 16, 2023

Study Record Updates

• Last Update Posted (Actual): April 30, 2024
• Last Update Submitted That Met QC Criteria: April 27, 2024
• Last Verified: October 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Stomatognathic Diseases; Periodontal Diseases; Mouth Diseases; Peri-Implantitis
• Other Study ID Numbers: 20230208

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: Publication

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No